Danhong Injection for Cerebral Infarction:Clinical Observation
Zhang Jing, Bin Liu
Abstract
Zhang Jing, Bin Liu
Abstract
OBJECTIVE:To observe the curative effect of Danhong injection in treating cerebral infarction.METHODS:30 patients(trial group) were assigned to receive Danhong injection,while 26(control group) to receive Ligustrazine injection.The neurologic impairment score,clinical efficacy and ADRs during medication were compared between the two groups.RESULTS:The total effective rates in trial group vs.in control group were 86.67% vs.65.38%,showing significant differences between the two groups(P0.05).CONCLUSION:Danhong injection was proved to be safe and effective in treating cerebral infarction,and it is superior to Ligustrazine injection in curative efficacy.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To observe the curative effect of Danhong injection in treating cerebral infarction.METHODS:30 patients(trial group) were assigned to receive Danhong injection,while 26(control group) to receive Ligustrazine injection.The neurologic impairment score,clinical efficacy and ADRs during medication were compared between the two groups.RESULTS:The total effective rates in trial group vs.in control group were 86.67% vs.65.38%,showing significant differences between the two groups(P0.05).CONCLUSION:Danhong injection was proved to be safe and effective in treating cerebral infarction,and it is superior to Ligustrazine injection in curative efficacy.
Key concepts: Medicine, Cerebral infarction, Anesthesia, Clinical efficacy, Clinical trial, Surgery, Internal medicine, Ischemia